Evidence Gaps

Naftopidil vs propiverine (anticholinergic)

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
GRADE not reported

Naftopidil vs Eviprostat (phytotherapy)

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
GRADE not reported